Mankind Pharma Limited — Others, 14-07-2025: Trading Window

Mankind Pharma has announced a board meeting. The key agenda for this upcoming meeting includes considering and approving the financial results for the quarter. Additionally, the board will discuss the potential declaration of an interim dividend. This event is significant for shareholders, offering insights into the company's recent operational performance and potential returns. The trading window for Mankind Pharma's securities remains closed, aligning with insider trading guidelines for such material information.